Project phases

  • Phase I-2018: Done

WP1. Investigate multifunctional hybrid magnetic nanoparticles structure-property relationship

  • Phase II-2019: Done

WP2. Develop hybrid magnetic nanoparticle 99mTc radiolabeling procedure

WP3. In vitro evaluation of hybrid magnetic nanoparticles on normal and different pathological (tumoral and nontumoral) cells

WP4. In vivo biodistribution with quantitative evaluation of the new radiotracer on small animals (normal and tumoral tissues)

  • Phase III-2020: Done

WP5. Multimodal imaging evaluation of the obtained nanotracer using SPECT and MRI and comparison studies with fluorescent/PET on small animals